Inhibitors of EGFR pathways-XL647-Cell Signaling Pathway Inhibitors-Products-Jinan Liangfu Jinghe Pharmaceutical Technology Co., Ltd.

Products

Cell Signaling Pathway Inhibitors

·Inhibitors of BTK Pathway

·Inhibitors of EGFR pathways

·Inhibitors of VEGFR pathways

·Inhibitors of PDGFR pathways

·Inhibitors of PI3K-Akt-mTOR pathways

·Inhibitors of IGF pathways

·Inhibitors of JAK-STAT pathway

·Inhibitors of MAPK/ERK pathway

·Inhibitors of apoptosis pathway

·Inhibitors of HIF-1 pathway

·Inhibitors of other pathways

Small Molecule Compounds

Impurity Reference Standards

Others

	Address: 2766 Yingxiu Road, Jinan High-Tech Zone, China
	Tel: Sales: +86-531-88811783 Evaluation:+86-531-88806178 R&D: +86-531-88813691 Office: +86-531-88817621
	Fax: +86-531-88817925
	Zip Code: 250101
	Email: Trade Department: sales@trio-pharmatech.com G&D&E: register@trio-pharmatech.com yzxpj@trio-pharmatech.com R&D center:: newdrugs@trio-pharmatech.com

Cell Signaling Pathway Inhibitors

Now Position:Home > Products > Cell Signaling Pathway Inhibitors < Inhibitors of EGFR pathways

XL647(CAS:651031-01-5)

Product No.

TP1042A

Name

XL647

Synonyms

CAS Number

651031-01-5

Structure

Brief Description

XL647 is a novel spectrum-selective kinase inhibitor for EGFR, ErbB2, KDR, Flt-4 and EphB4 with IC50 of 0.3 nM, 16 nM, 1.5 nM, 8.7 nM and 1.4 nM,

Purity

>99%

Package

5mg, 10mg, 20mg, 50mg

QQ1：	1762738062
QQ2：	1919147143
MSN：	sales-trio
SKYPE：	janisa.yan